Neurocrine Biosciences Gross Profit (TTM) Insights

Neurocrine Biosciences Inc (NBIX)

137.67 +3.36 (+2.50%) USD | NASDAQ | Jun 28, 16:00

137.64 -0.03 (-0.02%) After-Hours: 20:00

Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 1996. Upgrade now.

Date	Value
March 31, 2024	1.943B
December 31, 2023	1.847B
September 30, 2023	1.745B
June 30, 2023	1.639B
March 31, 2023	1.571B
December 31, 2022	1.466B
September 30, 2022	1.369B
June 30, 2022	1.279B
March 31, 2022	1.192B
December 31, 2021	1.119B
September 30, 2021	1.056B
June 30, 2021	1.020B
March 31, 2021	1.034B
December 31, 2020	1.036B
September 30, 2020	1.032B
June 30, 2020	996.50M
March 31, 2020	878.40M
December 31, 2019	780.70M
September 30, 2019	669.01M
June 30, 2019	599.31M
March 31, 2019	513.46M
December 31, 2018	446.30M
September 30, 2018	410.15M
June 30, 2018	320.28M
March 31, 2018	230.51M

Date	Value
December 31, 2017	160.37M
September 30, 2017	66.62M
June 30, 2017	6.274M
March 31, 2017	0.00
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012
December 31, 2011

Gross Profit Definition

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

599.31M

Minimum

Jun 2019

1.943B

Maximum

Mar 2024

1.214B

Average

1.088B

Median

Gross Profit (TTM) Benchmarks